Dorsey Wright & Associates Cytosorbents Corp Transaction History

Dorsey Wright & Associates

  • $376 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020
SELL
$7.37 - $11.54 $6,728 - $10,536
-913 Closed
0 $0
Q2 2020

Jul 23, 2020
BUY
$6.28 - $10.59 $5,733 - $9,668
913 New
913 $9,000
Q4 2018

Jan 07, 2019
SELL
$7.05 - $12.64 $8,925 - $16,002
-1,266 Closed
0 $0
Q3 2018

Oct 12, 2018
BUY
$10.95 - $14.8 $13,862 - $18,736
1,266 New
1,266 $16,000

Others Institutions Holding CTSO

# of Institutions
55
Shares Held
16.9M
Call Options Held
10.1K
Put Options Held
500
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $51.9M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email